Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

计划入组 8 人 · 首次发布于 2024 年 11 月 12 日

Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

计划入组 12 人 · 首次发布于 2026 年 7 月 22 日

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

计划入组 5 人 · 首次发布于 2024 年 11 月 29 日

anti-CD19 CAR-T cell therapy

PB-CD19-CAR T-cell therapy

Humanized CD19 CAR-T cell therapy (Yake)

CARGO Therapeutics

United States

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Bispecific CD20/CD19 CAR T-Cell Therapy Shows Promising Results in Mantle Cell Lymphoma

CD19 CAR T-Cell Therapy Demonstrates Promising Activity in Richter Transformation Despite Modest Outcomes

CD19 CAR-T Cell Therapy Shows Promise in Relapsed t(8;21) AML Despite Short-Term Remission